| scholarly article | Q13442814 |
| P50 | author | Adam E. Snook | Q45277404 |
| Gene S. Tan | Q47502916 | ||
| Scott A. Waldman | Q54290173 | ||
| Matthias J. Schnell | Q61864440 | ||
| Ruth Birbe | Q40108791 | ||
| P2093 | author name string | Peng Li | |
| Lan Huang | |||
| Benjamin J Stafford | |||
| Laurence C Eisenlohr | |||
| Stephanie Schulz | |||
| Jay L Rothstein | |||
| Mathew Thakur | |||
| P2860 | cites work | Epitopes derived by incidental translational frameshifting give rise to a protective CTL response | Q43635983 |
| In vivo imaging of human colon cancer xenografts in immunodeficient mice using a guanylyl cyclase C--specific ligand | Q43909540 | ||
| Vaccine therapy of established tumors in the absence of autoimmunity | Q44480751 | ||
| Guanylyl cyclase C is a marker of intestinal metaplasia, dysplasia, and adenocarcinoma of the gastrointestinal tract | Q45309641 | ||
| Th cell-deficient mice control influenza virus infection more effectively than Th- and B cell-deficient mice: evidence for a Th-independent contribution by B cells to virus clearance | Q45744355 | ||
| CTL access to tissue antigen is restricted in vivo | Q48088896 | ||
| Molecular and immunological evaluation of the expression of cancer/testis gene products in human colorectal cancer. | Q54582568 | ||
| Strong cellular and humoral anti-HIV Env immune responses induced by a heterologous rhabdoviral prime–boost approach | Q57165945 | ||
| Escherichia coli heat-stable enterotoxin receptors. A novel marker for colorectal tumors. | Q67500863 | ||
| Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2 | Q70224204 | ||
| Prime-boost immunization with DNA vaccine: mucosal route of administration changes the rules | Q73785342 | ||
| Vector-based vaccine/cytokine combination therapy to enhance induction of immune responses to a self-antigen and antitumor activity | Q78386134 | ||
| Expression of a natural tumor antigen by thymic epithelial cells impairs the tumor-protective CD4+ T-cell repertoire | Q80385175 | ||
| Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis | Q81300213 | ||
| Promiscuous thymic expression of an autoantigen gene does not result in negative selection of pathogenic T cells | Q81375532 | ||
| Mucosally restricted antigens as novel immunological targets for antitumor therapy | Q84239803 | ||
| CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice | Q24286950 | ||
| Projection of an immunological self shadow within the thymus by the aire protein | Q28207164 | ||
| Aire regulates negative selection of organ-specific T cells | Q28213185 | ||
| Cancer/testis antigens: an expanding family of targets for cancer immunotherapy | Q28215652 | ||
| Bile acids induce ectopic expression of intestinal guanylyl cyclase C Through nuclear factor-kappaB and Cdx2 in human esophageal cells | Q28235080 | ||
| A validated quantitative assay to detect occult micrometastases by reverse transcriptase-polymerase chain reaction of guanylyl cyclase C in patients with colorectal cancer | Q28256902 | ||
| Guanylyl cyclase C suppresses intestinal tumorigenesis by restricting proliferation and maintaining genomic integrity | Q28509565 | ||
| Guanylyl cyclase is a heat-stable enterotoxin receptor | Q28581707 | ||
| Disruption of the guanylyl cyclase-C gene leads to a paradoxical phenotype of viable but heat-stable enterotoxin-resistant mice | Q28591312 | ||
| Cancer statistics, 2005 | Q29617572 | ||
| Retinoic acid imprints gut-homing specificity on T cells | Q29619126 | ||
| Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria | Q29619620 | ||
| CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance | Q29620412 | ||
| Rapid acquisition of tissue-specific homing phenotypes by CD4(+) T cells activated in cutaneous or mucosal lymphoid tissues | Q33183256 | ||
| Mucosal immunity and gastrointestinal antigen processing | Q33816879 | ||
| Guanylyl cyclases and signaling by cyclic GMP. | Q33917038 | ||
| Targeting the mucosa: genetically engineered vaccines and mucosal immune responses | Q34150478 | ||
| Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells | Q34211233 | ||
| Second-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 gag have greatly reduced pathogenicity but are highly immunogenic | Q34461764 | ||
| Chemokines and the tissue-specific migration of lymphocytes | Q34515703 | ||
| Immunogenicity of cytopathic and noncytopathic viral vectors | Q34716855 | ||
| Immunology and immunotherapy of colorectal cancer | Q35097710 | ||
| Cancer immunotherapy: a treatment for the masses | Q35833153 | ||
| Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge | Q35884740 | ||
| Guanylyl cyclase C: a molecular marker for staging and postoperative surveillance of patients with colorectal cancer. | Q36252178 | ||
| Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction | Q36401408 | ||
| Guanylyl cyclase C is a selective marker for metastatic colorectal tumors in human extraintestinal tissues | Q37053969 | ||
| The importance of local mucosal HIV-specific CD8(+) cytotoxic T lymphocytes for resistance to mucosal viral transmission in mice and enhancement of resistance by local administration of IL-12. | Q37388157 | ||
| CD4+ T helper cell response is required for memory in CD8+ T lymphocytes induced by a poly(I:C)-adjuvanted MHC I-restricted peptide epitope | Q40217583 | ||
| The impact of misfolding versus targeted degradation on the efficiency of the MHC class I-restricted antigen processing. | Q40455083 | ||
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunotherapy | Q1427096 |
| tumor metastasis | Q120912381 | ||
| P304 | page(s) | 950-961 | |
| P577 | publication date | 2008-06-24 | |
| P1433 | published in | Journal of the National Cancer Institute | Q400279 |
| P1476 | title | Guanylyl cyclase C-induced immunotherapeutic responses opposing tumor metastases without autoimmunity | |
| P478 | volume | 100 |
| Q48165994 | A monomethyl auristatin E-conjugated antibody to guanylyl cyclase C is cytotoxic to target-expressing cells in vitro and in vivo |
| Q35572696 | A uroguanylin-GUCY2C endocrine axis regulates feeding in mice |
| Q35155933 | Bacterial heat-stable enterotoxins: translation of pathogenic peptides into novel targeted diagnostics and therapeutics |
| Q33610075 | Bile acids initiate lineage-addicted gastroesophageal tumorigenesis by suppressing the EGF receptor-AKT axis |
| Q38263819 | CANCER MUCOSA ANTIGENS A NOVEL PARADIGM IN CANCER IMMUNOTHERAPEUTICS |
| Q33701465 | Colorectal cancer immunotherapy |
| Q58924851 | Could targeting T-helper cells aid the development of effective cancer vaccines? |
| Q37954322 | Cure and curse: E. coli heat-stable enterotoxin and its receptor guanylyl cyclase C |
| Q37283135 | Cytokine adjuvanation of therapeutic anti-tumor immunity targeted to cancer mucosa antigens |
| Q45277310 | Epitope-targeted cytotoxic T cells mediate lineage-specific antitumor efficacy induced by the cancer mucosa antigen GUCY2C. |
| Q34619403 | GUCY2C lysosomotropic endocytosis delivers immunotoxin therapy to metastatic colorectal cancer |
| Q41625041 | GUCY2C-directed CAR-T cells oppose colorectal cancer metastases without autoimmunity |
| Q37950928 | GUCY2C-targeted cancer immunotherapy: past, present and future. |
| Q39120155 | Guanylate cyclase C as a target for prevention, detection, and therapy in colorectal cancer |
| Q37126006 | Immunotherapeutic strategies to target prognostic and predictive markers of cancer |
| Q35275167 | Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses |
| Q30488671 | Lineage-specific T-cell responses to cancer mucosa antigen oppose systemic metastases without mucosal inflammatory disease |
| Q58924834 | Non-thermal plasma induces immunogenic cell death in murine CT26 colorectal tumors |
| Q39142095 | Preclinical Evaluation of a Replication-Deficient Recombinant Adenovirus Serotype 5 Vaccine Expressing Guanylate Cyclase C and the PADRE T-helper Epitope |
| Q40274361 | Prime-Boost Immunization Eliminates Metastatic Colorectal Cancer by Producing High-Avidity Effector CD8+ T Cells |
| Q30584571 | Selective antigen-specific CD4(+) T-cell, but not CD8(+) T- or B-cell, tolerance corrupts cancer immunotherapy |
| Q64097244 | Split tolerance permits safe Ad5-GUCY2C-PADRE vaccine-induced T-cell responses in colon cancer patients |
| Q62746943 | TCR Retrogenic Mice as a Model To Map Self-Tolerance Mechanisms to the Cancer Mucosa Antigen GUCY2C |
| Q41669233 | The Heat-Stable Enterotoxin Receptor, Guanylyl Cyclase C, as a Pharmacological Target in Colorectal Cancer Immunotherapy: A Bench-to-Bedside Current Report |
| Q28067898 | The emerging role of immunotherapy in colorectal cancer |
| Q39802240 | The hormone receptor GUCY2C suppresses intestinal tumor formation by inhibiting AKT signaling. |
| Q56893452 | Trial watch: DNA-based vaccines for oncological indications |
| Q37666685 | Tumor radiation therapy creates therapeutic vaccine responses to the colorectal cancer antigen GUCY2C. |
Search more.